Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Current Deferred Revenue (2022 - 2025)

Jin Medical International (ZJYL) has disclosed Current Deferred Revenue for 4 consecutive years, with $495357.0 as the latest value for Q3 2025.

  • Quarterly Current Deferred Revenue fell 26.22% to $495357.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $495357.0 through Sep 2025, down 26.22% year-over-year, with the annual reading at $495357.0 for FY2025, 26.22% down from the prior year.
  • Current Deferred Revenue hit $495357.0 in Q3 2025 for Jin Medical International, down from $671414.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $830305.0 in Q3 2022 to a low of $119120.0 in Q3 2023.
  • Historically, Current Deferred Revenue has averaged $529049.0 across 4 years, with a median of $583385.5 in 2024.
  • Biggest five-year swings in Current Deferred Revenue: plummeted 85.65% in 2023 and later skyrocketed 463.65% in 2024.
  • Year by year, Current Deferred Revenue stood at $830305.0 in 2022, then tumbled by 85.65% to $119120.0 in 2023, then surged by 463.65% to $671414.0 in 2024, then decreased by 26.22% to $495357.0 in 2025.
  • Business Quant data shows Current Deferred Revenue for ZJYL at $495357.0 in Q3 2025, $671414.0 in Q3 2024, and $119120.0 in Q3 2023.